ea0049ep816 | Paediatric endocrinology | ECE2017
Donato Sara
, Andrade Sonia
, Dias Daniela
, Simoes-Pereira Joana
, da Conceicao Pereira Maria
Introduction: Asparaginase is a component of chemotherapy regimens used to treat paediatric acute lymphoblastic leukaemia (ALL). One of its well-known side effects is hyperglycaemia which is probably related to hypoinsulinemia. Its incidence rises significantly when associated with corticotherapy. We present two cases of diabetes related to asparaginase and corticoid administration.Case 1: Eleven-year-old girl diagnosed with an ALL. Before treatment she ...